Boston Scientific to Pay $296 Million in Settlement
Medical device maker Boston Scientific Corp. said Friday it will pay $296 million to settle a DOJ investigation into the company's Guidant unit. The investigation involved product advisories issued by Guidant in 2005, a year before Boston Scientific paid $27 billion for the heart device maker. Throughout 2007, Boston Scientific agreed to various settlements over heart patients' legal claims that Guidant knowingly sold defibrillators with potentially life-threatening defects.
